These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

976 related articles for article (PubMed ID: 25568920)

  • 1. Aryl hydrocarbon receptor ligands in cancer: friend and foe.
    Murray IA; Patterson AD; Perdew GH
    Nat Rev Cancer; 2014 Dec; 14(12):801-14. PubMed ID: 25568920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of a chloracne phenotype in an epidermal equivalent model by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is dependent on aryl hydrocarbon receptor activation and is not reproduced by aryl hydrocarbon receptor knock down.
    Forrester AR; Elias MS; Woodward EL; Graham M; Williams FM; Reynolds NJ
    J Dermatol Sci; 2014 Jan; 73(1):10-22. PubMed ID: 24161567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Aryl Hydrocarbon Receptor in Asthma: Friend or Foe?
    Poulain-Godefroy O; Bouté M; Carrard J; Alvarez-Simon D; Tsicopoulos A; de Nadai P
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Aryl Hydrocarbon Receptor and Tumor Immunity.
    Xue P; Fu J; Zhou Y
    Front Immunol; 2018; 9():286. PubMed ID: 29487603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of environmental aryl hydrocarbon receptor ligands on signaling and cell metabolism in cancer.
    Piwarski SA; Salisbury TB
    Biochem Pharmacol; 2023 Oct; 216():115771. PubMed ID: 37652105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential consequences of two distinct AhR ligands on innate and adaptive immune responses to influenza A virus.
    Wheeler JL; Martin KC; Resseguie E; Lawrence BP
    Toxicol Sci; 2014 Feb; 137(2):324-34. PubMed ID: 24194396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleotide specificity of DNA binding of the aryl hydrocarbon receptor:ARNT complex is unaffected by ligand structure.
    DeGroot DE; Denison MS
    Toxicol Sci; 2014 Jan; 137(1):102-13. PubMed ID: 24136190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A constitutively active dioxin/aryl hydrocarbon receptor promotes hepatocarcinogenesis in mice.
    Moennikes O; Loeppen S; Buchmann A; Andersson P; Ittrich C; Poellinger L; Schwarz M
    Cancer Res; 2004 Jul; 64(14):4707-10. PubMed ID: 15256435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From TCDD-mediated toxicity to searches of physiologic AHR functions.
    Bock KW
    Biochem Pharmacol; 2018 Sep; 155():419-424. PubMed ID: 30055148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-androgen flutamide suppresses hepatocellular carcinoma cell proliferation via the aryl hydrocarbon receptor mediated induction of transforming growth factor-β1.
    Koch DC; Jang HS; O'Donnell EF; Punj S; Kopparapu PR; Bisson WH; Kerkvliet NI; Kolluri SK
    Oncogene; 2015 Dec; 34(50):6092-104. PubMed ID: 25867062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dioxin and immune regulation: emerging role of aryl hydrocarbon receptor in the generation of regulatory T cells.
    Marshall NB; Kerkvliet NI
    Ann N Y Acad Sci; 2010 Jan; 1183():25-37. PubMed ID: 20146706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The aryl hydrocarbon receptor: a multifunctional chemical sensor for host defense and homeostatic maintenance.
    Kawajiri K; Fujii-Kuriyama Y
    Exp Anim; 2017 May; 66(2):75-89. PubMed ID: 27980293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aryl hydrocarbon receptor activation by cAMP vs. dioxin: divergent signaling pathways.
    Oesch-Bartlomowicz B; Huelster A; Wiss O; Antoniou-Lipfert P; Dietrich C; Arand M; Weiss C; Bockamp E; Oesch F
    Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9218-23. PubMed ID: 15972329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist.
    Prud'homme GJ; Glinka Y; Toulina A; Ace O; Subramaniam V; Jothy S
    PLoS One; 2010 Nov; 5(11):e13831. PubMed ID: 21072210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of aryl hydrocarbon receptor ligands derived from natural products in rheumatoid arthritis.
    Hui W; Dai Y
    Basic Clin Pharmacol Toxicol; 2020 Jun; 126(6):469-474. PubMed ID: 31811747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The search for endogenous activators of the aryl hydrocarbon receptor.
    Nguyen LP; Bradfield CA
    Chem Res Toxicol; 2008 Jan; 21(1):102-16. PubMed ID: 18076143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aryl hydrocarbon receptor control of adaptive immunity.
    Quintana FJ; Sherr DH
    Pharmacol Rev; 2013; 65(4):1148-61. PubMed ID: 23908379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aryl Hydrocarbon Receptor Activation Synergistically Induces Lipopolysaccharide-Mediated Expression of Proinflammatory Chemokine (c-c motif) Ligand 20.
    Lahoti TS; Boyer JA; Kusnadi A; Muku GE; Murray IA; Perdew GH
    Toxicol Sci; 2015 Nov; 148(1):229-40. PubMed ID: 26259605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transactivation domain of the Ah receptor is a key determinant of cellular localization and ligand-independent nucleocytoplasmic shuttling properties.
    Ramadoss P; Perdew GH
    Biochemistry; 2005 Aug; 44(33):11148-59. PubMed ID: 16101299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aryl hydrocarbon receptor mediates Jak2/STAT3 signaling for non-small cell lung cancer stem cell maintenance.
    Xiong J; Zhang X; Zhang Y; Wu B; Fang L; Wang N; Yi H; Chang N; Chen L; Zhang J
    Exp Cell Res; 2020 Nov; 396(1):112288. PubMed ID: 32941808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.